IVF denied as duplicate or overlapping therapy by Aetna?

Aetna's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denied IVF as Duplicate Therapy

A duplicate-therapy denial for in vitro fertilization (IVF) typically arises when Aetna's records indicate that you or your partner are currently approved for, or recently underwent, another fertility treatment that the plan considers to address the same underlying clinical indication — most commonly a prior IVF cycle that is classified as ongoing or within a benefit period, or a concurrent intrauterine insemination (IUI) protocol that has not been formally concluded in the plan's system.

For IVF specifically, this denial often reflects a benefit-cycle-counting issue rather than a true clinical duplicate — for example, the plan counting a failed or incomplete cycle as a completed cycle, or a concurrent treatment appearing in the claims system before a prior one is formally closed. It is very commonly resolved by clarifying the clinical and administrative record.

## Federal Appeal Framework

• ACA §2719 / ERISA §503: You are entitled to a full internal appeal with a written explanation of exactly which prior or concurrent treatment Aetna identified as duplicative, and the clinical or administrative basis for that determination.
• Right to information: Request in writing the specific claim or authorization record Aetna is relying on as the duplicate, as well as the criteria it applied.
• External review: If the internal appeal is denied, you may escalate to an IRO. You generally have approximately four months from the denial date to file for external review — confirm the exact deadline from your denial letter.
• Expedited option: Reproductive medicine involves time-sensitive biological windows; if delay would materially affect your clinical options (for example, ovarian reserve considerations), document that urgency and request expedited review.

## Concrete Appeal Process and Timeline

1. Request from Aetna the full denial reason, identifying specifically which treatment it considers duplicative and the policy language applied. 2. Have the treating reproductive endocrinologist review the determination and document why the proposed IVF cycle is clinically distinct from any prior or concurrent treatment. 3. File a written internal appeal within Aetna's stated deadline (typically 180 days from the denial). 4. Aetna must respond to prospective appeals within 30 days and retrospective appeals within 60 days. 5. If denied internally, file for IRO external review before the four-month window closes.

## Documentation to Gather

• Diagnosis confirmation: Records from the treating reproductive endocrinologist confirming the diagnosis of infertility (or the specific underlying condition) and the clinical basis for recommending IVF at this time.
• Prior-treatment history with dates and outcomes: A complete chronological account of all prior fertility treatments — what was done, when, and the clinical outcome — as documented in the medical record. This allows the reviewer to confirm which cycles were completed, incomplete, or abandoned for documented clinical reasons.
• Clinical differentiation: If Aetna identified a specific prior treatment as the "duplicate," documentation from the chart showing why the new IVF cycle is a distinct clinical intervention — different indication, different protocol, different benefit period, or different clinical circumstances.
• Prescriber letter: A letter from the reproductive endocrinologist explaining the clinical rationale for the current IVF cycle and why it is not duplicative of any prior or concurrent treatment covered by the plan.

## Criteria-Mapping Structure

Obtain Aetna's duplicate-therapy policy language. Then map your evidence:

| Policy Criterion | Patient-Specific Evidence | |---|---| | Prior or concurrent treatment identified by plan | [Identify which treatment; confirm it is completed/closed in record] | | Current IVF cycle is clinically and administratively distinct | [Chart documentation, dates, clinical rationale] | | Benefit period or cycle-count analysis | [Demonstrate available benefit using plan's own benefit document] |

Attach all referenced records and, importantly, the relevant section of the plan's benefit document showing available IVF cycles. Administrative duplicate denials often resolve quickly when the plan's own records are corrected.